This information was published on 2026-06-04T10:10:58 for IP Right Registration Published.
| Field | Value |
| (210) | 2632729 (IR 1905207) |
| (220) |
03 Feb 2026
|
| (300) |
TO, 04 Aug 2025, TO/M/2025/04911
|
| (511) (510) |
Class 5
Pharmaceuticals; pharmaceutical preparations; pharmaceuticals for the treatment of mental health conditions; pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, depression, post-traumatic stress disorder, and mood disorders; pharmaceutical preparations for the treatment of substance-use and addictive disorders. Class 42 Drug discovery services; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the fields of psychiatry, neurology, and addiction medicine; medical and scientific research, namely, conducting clinical trials for others in the field of psychedelic-based therapeutics. |
| (540) | DEFINIUM |
| (550) | Word |
| (730) |
Definium Therapeutics US, Inc.
|
Find out more about publications on the About page.